As per the Securities and Exchange Board of India (SEBI) Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/76 dated May 30, 2022, the Shareholders holding Shares of Astec LifeSciences Limited (“the Company”) are hereby informed that in case if you have any dispute against the Company and / or, the Registrar and Share Transfer Agent (RTA), for any delay or default in processing your request, you can file for arbitration with BSE Limited (“BSE”) and National Stock Exchange of India Limited (NSE), the Stock Exchanges where the Equity Shares of the Company are listed. For more details, please access the below the weblinks of the Stock Exchanges-

BSE

https://www.bseindia.com/static/investors/Complaint_against_Companies.aspx

https://bsecrs.bseindia.com/ecomplaint/frmInvestorHome.aspx

NSE

https://www.nseindia.com/invest/about-arbitration